Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 135
- Press releases
Chanelle McCoy Granted Approval For Significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial
PRESS RELEASE R&D Pharmaceutical company, Chanelle McCoy Health, founded by Lady Chanelle McCoy and Caroline Glynn, are pleased to announce they have received Ethics Approval from Bellberry Human Research Ethics Committee in Australia.
- Pharmaceutical
European Cannabis Stocks Review: Akanda Reports $2.3m Loss From Bophelo, OCT Shares Spike & Cellular Goods Sales Slow
Akanda Akanda unveiled its unaudited financial figures for the six months to the end of June 2022, two weeks after revealing that its CEO has been on ‘paid leave of absence’ since November.
- CBD Market
Big Win For French CBD Industry As Ban On Flowers Officially Scrapped, But Government Response Suggests Issue ‘Far From Over’
FRANCE’s highest court, the Council of State, has officially scrapped an attempted ban on the sale of CBD flowers and leaves.
- Adult-Use
What’s In Store For The European Cannabis Industry In 2023? (Part 2)
You can read Part 1 of our 2023 predictions here. Enexis AB According to the cannabis investment firm Enexis, economic pressures will mean capital available for the European cannabis industry will be ‘scarce’ in the first half of 2023; however, it predicts that this will begin to ‘rebound thereafter’.
- Adult-Use
What’s In Store For The European Cannabis Industry In 2023? (Part 1)
Following a milestone year for European cannabis in 2021, which saw many companies take advantage of a wave of excitement surrounding the young industry’s potential, 2022 saw this wave break sooner than many expected. 2023 is expected to bring yet more change.
- Adult-Use
Business<em>Cann</em>’s Top 10 Stories of 2022 – A Sticky Year For European Cannabis Ends On A High
TWELVE months ago we were recapping on what many were calling a break- through year for European cannabis following dramatic events in Germany with the new Government promising the continent’s first legalised adult-use market.
- Adult-Use
European Cannabis Round-Up: New Figures Show Healthy Growth In Czech Medical Cannabis, Goodbody Health Sells CBD Facility, & French Study Reveals Ageing Cannabis Users
Czechia’s Medical Cannabis AS Czechia races ahead with plans to launch a fully regulated adult-use cannabis market, with the potential to beat Germany to the punch, new data suggests its medical cannabis market is also experiencing healthy growth.
- Companies
European Cannabis Stocks See Hundreds Of Millions Wiped Off Value In 2022, 3 Board Members Leave Love Hemp, & More From SEED Innovations
European Cannabis Stocks 2022 Cannabis companies across Europe have had an extremely difficult year on the markets, with more than £1bn wiped off their collective market value.
- Adult-Use
Cultivator Hellenic Dynamics Poised To Hit The Ground Running After Long-Fought IPO
HELLENIC Dynamics became the first pureplay cannabis cultivator to list on the London Stock Exchange (LSE) last week after nearly two years of negotiations with the FCA.
- Companies
Financial Giant Euroclear Announces Plans To Stop Supporting ‘Cannabis-Related Stocks’
EUROCLEAR, one of the world’s largest financial clearing houses which serves 90% of the world’s 50 largest banks, has informed investors that it will ‘no longer support international cannabis-related stocks’ from January 2023.
- Adult-Use
Europe’s First THC Adult-Use Cannabis Trial Set To Launch In January 2023 After Four Month Delay
SWITZERLAND’s ‘Weed Care’ pilot, set to be Europe’s first ever THC adult-use cannabis trial, is now due to begin on January 30, 2023 following a four-month delay.
- Pharmaceutical
Greencare Capital To ‘Withdraw’ From ‘Difficult’ Cannabis Market, OCT Shares Jump As New CEO Appointed, & More From MGC Pharma
Oxford Cannabinoid Technologies Oxford Cannabinoid Technologies (OCT) has seen its share price jump by more than 20% this week after announcing that its CEO Dr John Lucas would be stepping down.











